Effects of Electrostimulation on Glycemic Control in Obesity
NCT ID: NCT04643899
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-03-29
2023-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion
NCT04389736
Effects of Neuro-myo-electrical Stimulation on Insulin Sensitivity in Patients With Type 2 Diabetes
NCT02510521
Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)
NCT02171351
Effects of Electrical Muscle Stimulation on Waist Circumference in Adults
NCT02970812
Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
NCT06722391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Muscle electrostimulation (MES) could therefore be an interesting additional tool in the management of obesity and particularly of glycemic control in obese patients suffering from type 2 diabetes.
Studies are still relatively few and present certain limits (small samples, short period of MES, very specific populations, few parameters evaluated, lack of consensus on the methods of MES, etc.). The results are nevertheless encouraging and call for the implementation of additional studies.
Investigators therefore propose a controlled, randomized, single-center study in a group of 60 adult patients suffering from severe or morbid obesity (BMI\> = 35) in a 3-week rehabilitation stay.
The aims are to establish whether MES is a possible and interesting tool in the management of obesity, by checking the following hypotheses:
* control of carbohydrate metabolism is better when a MES is implemented;
* MES sessions improve patients' physical capacities and / or their tolerance to exercise;
* MES improves the quality of life of patients;
* MES improves patient adherence to the usual nutritional rehabilitation program;
* MES sessions are well tolerated and the accepted intensity nevertheless guarantees sufficient muscle stimulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
* Distribution of patients in groups according to a ratio (1: 1)
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients benefiting only from the usual nutritional rehabilitation program G1a: diabetic patients G1b: non-diabetic patients
No interventions assigned to this group
Electrostimulation group
Patients benefiting from the usual program AND muscle electrostimulation sessions G2a: diabetic patients G2b: non-diabetic patients
Muscle Electrostimulation
* Scheduled sessions of 20 minutes per day; 5 days a week
* In physiotherapy or in their room for the most dependent patients
* Installation and monitoring by a physiotherapist or by the trained clinical research nurse
* Modalities:
* Device program n ° 1: 20mn (2mn of warm-up, 15mn of work at 75hz, then 3mn of recovery)
* 4 electrodes (2 per thigh): large model (5 \* 10 cm) for better comfort - Dura-Stick Plus model (reference 42200)
* Gradual auto-increase of the intensity to the highest possible value tolerated, nevertheless allowing a contraction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Muscle Electrostimulation
* Scheduled sessions of 20 minutes per day; 5 days a week
* In physiotherapy or in their room for the most dependent patients
* Installation and monitoring by a physiotherapist or by the trained clinical research nurse
* Modalities:
* Device program n ° 1: 20mn (2mn of warm-up, 15mn of work at 75hz, then 3mn of recovery)
* 4 electrodes (2 per thigh): large model (5 \* 10 cm) for better comfort - Dura-Stick Plus model (reference 42200)
* Gradual auto-increase of the intensity to the highest possible value tolerated, nevertheless allowing a contraction
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with severe or morbid obesity (BMI\> = 35)
* with or without bariatric surgery
* able to understand and respect the protocol and its requirement
* who signed the consent prior to any other procedure protocol
Exclusion Criteria
* pregnant patients
* patients with epilepsy
* with an implanted electronic/electrical device (cardiac pacemaker, intracardiac defibrillator, etc.)
* with a baclofen pump
* suffering from serious disorders of the arterial circulation in the lower limbs such as Peripheral Arterial Obstructive Disease (PAOD)
* suffering from abdominal or inguinal hernia
* suffering from cardiac arrhythmia
* suffering from skin lesions and/or infections foci on one or more areas where the electrodes are placed
* suffering from sensory disorders in the areas of stimulation
* patients unable to complete the entire program
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
Fondation Ildys
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lena SEITE, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Ildys
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CF Center - Fondation Ildys Site de Perharidy
Roscoff, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grosset JF, Crowe L, De Vito G, O'Shea D, Caulfield B. Comparative effect of a 1 h session of electrical muscle stimulation and walking activity on energy expenditure and substrate oxidation in obese subjects. Appl Physiol Nutr Metab. 2013 Jan;38(1):57-65. doi: 10.1139/apnm-2011-0367. Epub 2012 Nov 12.
van Buuren F, Horstkotte D, Mellwig KP, Frund A, Vlachojannis M, Bogunovic N, Dimitriadis Z, Vortherms J, Humphrey R, Niebauer J. Electrical Myostimulation (EMS) Improves Glucose Metabolism and Oxygen Uptake in Type 2 Diabetes Mellitus Patients--Results from the EMS Study. Diabetes Technol Ther. 2015 Jun;17(6):413-9. doi: 10.1089/dia.2014.0315. Epub 2015 Mar 3.
Joubert M, Metayer L, Prevost G, Morera J, Rod A, Cailleux A, Parienti JJ, Reznik Y. Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot study. Acta Diabetol. 2015 Apr;52(2):285-91. doi: 10.1007/s00592-014-0636-5. Epub 2014 Aug 9.
Miyamoto T, Fukuda K, Kimura T, Matsubara Y, Tsuda K, Moritani T. Effect of percutaneous electrical muscle stimulation on postprandial hyperglycemia in type 2 diabetes. Diabetes Res Clin Pract. 2012 Jun;96(3):306-12. doi: 10.1016/j.diabres.2012.01.006. Epub 2012 Jan 30.
Vivodtzev I, Maffiuletti NA, Borel AL, Grangier A, Wuyam B, Tamisier R, Pepin JL. Acute Feasibility of Neuromuscular Electrical Stimulation in Severely Obese Patients with Obstructive Sleep Apnea Syndrome: A Pilot Study. Biomed Res Int. 2017;2017:3704380. doi: 10.1155/2017/3704380. Epub 2017 Jan 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB
Identifier Type: OTHER
Identifier Source: secondary_id
ILDYS-ISC2-2020001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.